China Approves Clinical Trial of Omicron Vaccine

By Lars James Hamer, April 28, 2022

0 0

A Chinese vaccination for the Omicron variant of COVID-19 has been approved for clinical trials, reports CGTN.

The vaccine was developed by the China National Biotec Group (which has affiliations with Sinopharm) and was approved by the National Medical Products Administration on Tuesday, April 26. 

Preliminary tests – such as safety evaluations in animals and immunogenicity research – showed that the vaccine is capable of producing antibodies that can fight off COVID variants, including Omicron. 

China National Biotec Group have previously developed COVID-19 vaccines in the country and conducted research into its many variants, including Beta and Delta. 

The trial will be carried out on adults aged 18 and above who have been inoculated with two or three doses of a COVID-19 vaccine.


[Cover image via Flickr]

more news

The Dead Require Negative COVID Test in Shenzhen

Screenshots of a funeral home stating COVID-19 tests for the deceased should be provided have been shared online.

China Easing COVID Entry Requirements from Some Countries

Notices from Chinese embassies in some countries indicate changes to requirements for inbound travellers.

China COVID Experts Outline 5 Strategies for Opening Up

Two of the country's top COVID-19 experts have said China's "prolonged dynamic zeroing cannot be pursued in the long run."

Detention for Those Found Refusing or Faking a COVID-19 Test

Don't break China's Law on the Prevention and Treatment of Infectious Diseases.

New COVID-19 Omicron Variant Identified in Suzhou

The BA.1.1 variant of omicron has not been identified anywhere else in the world.

China Implements Anti-COVID-19 Measures on International Mail

Upon arrival in China, international mail will be disinfected and held for up to seven days before delivery. However, given what we know about how long the virus can survive on different surfaces and reacts to temperature changes, is it necessary?

Does China’s Omicron Outbreak Represent a COVID Turning Point?

The latest outbreak might have a silver lining.

0 User Comments

In Case You Missed It…

We're on WeChat!

Scan our QR Code at right or follow us at ThatsSuzhou for events, guides, giveaways and much more!

7 Days in Suzhou With thatsmags.com

Weekly updates to your email inbox every Wednesday

Subscribe

Download previous issues

Never miss an issue of That's Suzhou!

Visit the archives